Akeso (HKG:9926) granted 7,115,000 share options to 114 grantees under its share option scheme at an exercise price of HK$84.60 apiece, according to a Monday filing with the Hong Kong bourse.
Chairperson Xia Yu is entitled to 3 million share options, the filing said.
The biopharmaceutical company will also offer 3,420,000 restricted share units to 107 grantees, including Xia, who will be entitled to 2 million RSUs, and six other directors.
The closing price of the shares is HK$83.15 per share, the filing said.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。